- Home
- GILT vs IMTX Comparison
GILT vs IMTX Comparison
Compare GILT & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GILT | IMTX |
|---|---|---|
| Founded | 1987 | N/A |
| Country | Israel | Germany |
| Employees | N/A | 407 |
| Industry | Radio And Television Broadcasting And Communications Equipment | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.3B |
| IPO Year | 1997 | N/A |
Fundamental Metrics
Financial Performance| Metric | GILT | IMTX |
|---|---|---|
| Price | $18.54 | $10.73 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | $19.00 | $19.00 |
| AVG Volume (30 Days) | ★ 573.2K | 341.8K |
| Earning Date | 05-18-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $15.06 | N/A |
| Revenue Next Year | $11.72 | $25.91 |
| P/E Ratio | $42.82 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.43 | $3.94 |
| 52 Week High | $20.38 | $12.41 |
Technical Indicators
Market Signals| Indicator | GILT | IMTX |
|---|---|---|
| Relative Strength Index (RSI) | 58.81 | 58.47 |
| Support Level | $13.38 | $9.61 |
| Resistance Level | $19.90 | $11.30 |
| Average True Range (ATR) | 1.02 | 0.47 |
| MACD | 0.20 | 0.10 |
| Stochastic Oscillator | 83.49 | 79.57 |
Price Performance
Historical ComparisonAbout GILT Gilat Satellite Networks Ltd.
Gilat Satellite Networks Ltd is a provider of satellite-based broadband communications. The company designs and manufactures ground-based satellite communications equipment and provides comprehensive solutions and end-to-end services. Its portfolio includes a cloud-based satellite network platform, very small aperture terminals (VSATs), amplifiers, high-speed modems, on-the-move antennas and high-power solid-state power amplifiers (SSPAs), block-up converters (BUCs), and Transceivers. The company operates in three operating segments: Gilat Commercial Division, Gilat Defense Division, and Gilat Peru Division. The majority of its revenue is generated from the Gilat Commercial segment.
About IMTX Immatics N.V.
Immatics NV is a clinical-stage biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.